Topigs Norsvin achieved solid profit growth in 2024, with net profit tripling to €7,7 million and turnover increasing by 12% to over €300 million.
The increasing global demand for pig genetics, especially in Spain, Brazil and North America, is the basis for this success. The company also managed to gain market share in shrinking markets such as the Netherlands, Germany and Denmark.
Progress
Topigs Norsvin genetics are increasingly being chosen by large integrations, including Muyuan Foods in China. Partly due to this growth, the company will invest €2025 million in R&D in 37, an increase of 9%. This should lead to faster genetic progress and cost reduction for customers.
According to CFO Pieter van Sundert, the figures prove that previous investments in breeding are paying off. Chairman Mark Tijssen calls the importance of the cooperative model the basis for growth: "We are fully owned by pig farmers and continue to build a strong market position at home and abroad."
© DCA Market Intelligence. This market information is subject to copyright. It is not permitted to reproduce, distribute, disseminate or make the content available to third parties for compensation, in any form, without the express written permission of DCA Market Intelligence.